Results 1 to 10 of about 2,534,766 (303)

Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study

open access: yesFrontiers in Immunology, 2023
BackgroundMolecular targeted therapy combined with immunotherapy significantly improves the prognosis of patients with advanced liver cancer. Additionally, hepatic arterial infusion chemotherapy (HAIC) can improve the prognosis of patients with advanced ...
Weihao Zhang   +41 more
doaj   +1 more source

Roux-en-Y Gastric Bypass as an Effective Bariatric Revisional Surgery after Restrictive Procedures

open access: yesObesity Facts, 2020
Introduction: Revisional surgery must be considered when insufficient weight loss is attained or weight is subsequently regained. This study aimed to investigate the value of Roux-en-Y gastric bypass (RYGB) as a revisional procedure after restrictive ...
Rosa Marti-Fernandez   +6 more
doaj   +1 more source

Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment

open access: yesFrontiers in Oncology, 2020
Pancreatic ductal adenocarcinoma (PDAC) has still a dismal prognosis, mainly because only 15–20% of all patients present with resectable tumor stages at the time of diagnosis.
Ulla Klaiber, Thilo Hackert
doaj   +1 more source

Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment

open access: yesJGH Open, 2022
Background and Aim Conversion surgery (CS), which aims to cure after systematic therapy, is only scarcely reported in the field of hepatocellular carcinoma (HCC).
Shun Kaneko   +22 more
doaj   +1 more source

Minimally invasive surgery is feasible after preoperative chemotherapy for stage IV gastric cancer

open access: yesAnnals of Gastroenterological Surgery, 2020
Aim To elucidate the safety and feasibility of minimally invasive surgery (MIS) as conversion surgery after chemotherapy for stage IV gastric cancer, we compared the background characteristics and clinical courses of patients who underwent open ...
Kazuyoshi Yamamoto   +9 more
doaj   +1 more source

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer

open access: yesCurrent Oncology, 2023
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. The 5-year survival rate after curative resection is almost 80%, however, it is still less than satisfactory for metastatic CRC (mCRC).
Yoshihito Kano   +2 more
doaj   +1 more source

Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study

open access: yesFrontiers in Oncology, 2022
BackgroundNeoadjuvant intraperitoneal and systemic chemotherapy (NIPS) has shown promising results in gastric cancer (GC) with peritoneal metastasis. However, clinical practice experience of NIPS is still lacking in China.
Zhong-Yin Yang   +19 more
doaj   +1 more source

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer

open access: yesAnnals of Gastroenterological Surgery, 2023
Purpose Gemcitabine, cisplatin, and S‐1 chemotherapy was superior to gemcitabine and cisplatin chemotherapy for progression‐free survival and overall survival for unresectable and recurrent biliary tract cancer in a randomized phase III trial (KHBO1401).
Ikuo Nakamura   +9 more
doaj   +1 more source

Successful Preoperative QUAD SHOT for Bulky Parotid Carcinoma: Potential Preoperative Ultra-Hypofractionated Radiotherapy for Conversion Surgery

open access: yesCase Reports in Oncology, 2023
QUAD SHOT is an ultra-hypofractionated radiotherapy (RT) technique that prescribes 14.0–14.8 Gy over 2 days. Although this technique has already gained some status as an effective palliative treatment for inoperable head and neck cancer (HNC), its ...
Satoru Takahashi   +15 more
doaj   +1 more source

Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

open access: yesMedicina
Background and Objectives: Conversion surgery for liver metastatic colorectal cancer (mCRC) has been associated with prolonged survival. This study aimed to evaluate the efficacy and safety of integrating biological therapies with fluorouracil-based ...
Furkan Ceylan   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy